Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-26-001201
Filing Date
2026-02-17
Accepted
2026-02-17 16:57:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 12217
  Complete submission text file 0001172661-26-001201.txt   14003
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Subject) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-40503 | Film No.: 26643161
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 1177 AVE. OF THE AMERICAS 46TH FLOOR NEW YORK NY 10036
Business Address 1177 AVE. OF THE AMERICAS 46TH FLOOR NEW YORK NY 10036 212-626-1421
Gates Capital Management, Inc. (Filed by) CIK: 0001312908 (see all company filings)

EIN.: 133886865 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A